{"schema_version":"1","generated_at":"2026-11-02T13:29:55.707Z","data_as_of":null,"url":"https://www.findmykol.com/kol/taylor-sandison","json_url":"https://www.findmykol.com/kol/taylor-sandison/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"taylor-sandison","name":"Taylor Sandison","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1033166624","openalex":"A5113678719"},"summary":"Taylor Sandison is an Infectious Disease physician. OpenAlex indexes 60 publications with 1,499 citations (h-index 20); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":60,"cited_by_count":1499,"h_index":20,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07215273","title":"Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Elion Therapeutics, Inc.","source_url":"https://clinicaltrials.gov/study/NCT07215273","trial_url":"https://www.findmykol.com/trial/NCT07215273"},{"nct":"NCT03667690","title":"Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis","phase":"PHASE3","status":"COMPLETED","role":"Overall official","sponsor":"Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","source_url":"https://clinicaltrials.gov/study/NCT03667690","trial_url":"https://www.findmykol.com/trial/NCT03667690"},{"nct":"NCT02734862","title":"CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension","phase":"PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","source_url":"https://clinicaltrials.gov/study/NCT02734862","trial_url":"https://www.findmykol.com/trial/NCT02734862"}],"source":"trials"},"funding":{"award_count":1,"fiscal_years":{"first":2009,"last":2010},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"K23AI082553","title":"Rebound Malaria Following Trimethoprim-Sulfamethoxazole Prophylaxis in Children","fiscal_year":2010,"amount_usd":"39311","organization":"UNIVERSITY OF WASHINGTON","source_url":"https://reporter.nih.gov/quickSearch/K23AI082553"},{"project":"K23AI082553","title":"Rebound Malaria Following Trimethoprim-Sulfamethoxazole Prophylaxis in Children","fiscal_year":2009,"amount_usd":"131409","organization":"UNIVERSITY OF WASHINGTON","source_url":"https://reporter.nih.gov/quickSearch/K23AI082553"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"573. CD388, a Novel Drug-Fc Conjugate (DFC), Demonstrates Prophylactic Activity in an Influenza Human Challenge Model","year":2025,"journal":"Open Forum Infectious Diseases","source_url":"https://doi.org/10.1093/ofid/ofae631.174","status":"verified"},{"title":"Outcomes by <i>Candida</i> spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and/or invasive candidiasis","year":2024,"journal":"Antimicrobial Agents and Chemotherapy","source_url":"https://doi.org/10.1128/aac.01584-23","status":"verified"},{"title":"The distinctive pharmacokinetic profile of rezafungin, a long-acting echinocandin developed in the era of modern pharmacometrics","year":2024,"journal":"Journal of Antimicrobial Chemotherapy","source_url":"https://doi.org/10.1093/jac/dkae415","status":"verified"},{"title":"Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials","year":2024,"journal":"Critical Care","source_url":"https://doi.org/10.1186/s13054-024-05117-5","status":"verified"},{"title":"Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trials","year":2024,"journal":"Critical Care","source_url":"https://doi.org/10.1186/s13054-024-05152-2","status":"verified"}],"source":"works"},"contact":{"address_1":"1959 NE PACIFIC ST","city":"Seattle","state":"WA","zip":"981950001","phone":"206-598-3000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1033166624","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"},{"name":"Myron Cohen","slug":"myron-cohen","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/myron-cohen","json_url":"https://www.findmykol.com/kol/myron-cohen/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-08-19","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}